Erbin and the NF2 Tumor Suppressor Merlin Cooperatively Regulate Cell-Type-Specific Activation of PAK2 by TGF-β

Developmental Cell

Volumn 16, Issue 3, 2009, Pages 433-444

  Wilkes, Mark C ^a   Repellin, Claire E ^a   Hong, Min ^a   Bracamonte, Margarita ^a   Penheiter, Sumedha G ^a   Borg, Jean Paul ^b   Leof, Edward B ^a  

^a MAYO CLINIC CANCER CENTER   (United States)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERBIN; GUANOSINE TRIPHOSPHATASE; MERLIN; P21 ACTIVATED KINASE 2; REGULATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; CDC42 GTP-BINDING PROTEIN; CELL LINE; EPITHELIAL CELLS; FIBROBLASTS; MICE; MODELS, BIOLOGICAL; NEUROFIBROMIN 2; NEUROPEPTIDES; P21-ACTIVATED KINASES; PROTEIN BINDING; RAC GTP-BINDING PROTEINS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 61749090602     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.devcel.2009.01.009     Document Type: Article

References (46)

1. Anders R.A., and Leof E.B. Chimeric granulocyte/macrophage colony-stimulating factor/transforming growth factor-β (TGF-β) receptors define a model system for investigating the role of homomeric and heteromeric receptors in TGF-β signaling. J. Biol. Chem. 271 (1996) 21758-21766
2. Atalay A., Crook T., Ozturk M., and Yulug I.G. Identification of genes induced by BRCA1 in breast cancer cells. Biochem. Biophys. Res. Commun. 299 (2002) 839-846
3. Azuma M., Nishioka Y., Aono Y., Inayama M., Makino H., Kishi J., Shono M., Kinoshita K., Uehara H., Ogushi F., et al. Role of α1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice. Am. J. Respir. Cell Mol. Biol. 176 (2007) 1243-1250
4. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., and Arteaga C.L. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275 (2000) 36803-36810
5. Bhowmick N.A., and Moses H.L. Tumor-stroma interactions. Curr. Opin. Genet. Dev. 15 (2005) 97-101
6. Borg J.P., Marchetto S., Le Bivic A., Ollendorff V., Jaulin-Bastard F., Saito H., Fournier E., Adelaide J., Margolis B., and Birnbaum D. ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. Nat. Cell Biol. 2 (2000) 407-414
7. Bretscher A., Chambers D., Nguyen R., and Reczek D. ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu. Rev. Cell Dev. Biol. 16 (2000) 113-143
8. Chaudhary N.I., Schnapp A., and Park J.E. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am. J. Respir. Crit. Care Med. 173 (2006) 769-776
9. Curto M., and McClatchey A.I. Nf2/Merlin: a coordinator of receptor signaling and intercellular contact. Br. J. Cancer 98 (2008) 256-262
10. Dai F., Chang C., Lin X., Dai P., Mei L., and Feng X.H. Erbin inhibits transforming growth factor β signaling through a novel Smad-interacting domain. Mol. Cell. Biol. 27 (2007) 6183-6194
11. Dai P., Xiong W.C., and Mei L. Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex. J. Biol. Chem. 281 (2006) 927-933
12. Daniels C.E., Wilkes M.C., Edens M., Kottom T.J., Murphy S.J., Limper A.H., and Leof E.B. Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis. J. Clin. Invest. 114 (2004) 1303-1316
13. Dardousis K., Voolstra C., Roengvoraphoj M., Sekandarzad A., Mesghenna S., Winkler J., Ko Y., Hescheler J., and Sachinidis A. Identification of differentially expressed genes involved in the formation of multicellular tumor spheroids by HT-29 colon carcinoma cells. Mol. Ther. 15 (2007) 94-102
14. Feng X.-H., and Derynck R. Specificity and versatility in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 21 (2005) 659-693
15. Flanders K.C. Smad3 as a mediator of the fibrotic response. Int. J. Exp. Pathol. 85 (2004) 47-64
16. Fryer B.H., and Field J. Rho, Rac, Pak and angiogenesis: old roles and newly identified responsibilities in endothelial cells. Cancer Lett. 229 (2005) 13-23
17. Gobbi H., Arteaga C.L., Jensen R.A., Simpson J.F., Dupont W.D., Olson S.J., Schuyler P.A., Plummer Jr. W.D., and Page D.L. Loss of expression of transforming growth factor β type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Histopathology 36 (2000) 168-177
18. Huang F.Y., Chiu P.M., Tam K.F., Kwok Y.K., Lau E.T., Tang M.H., Ng T.Y., Liu V.W., Cheung A.N., and Ngan H.Y. Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer. Gynecol. Oncol. 103 (2006) 219-225
19. Huang Y.Z., Zang M., Xiong W.C., Luo Z., and Mei L. Erbin suppresses the MAP kinase pathway. J. Biol. Chem. 278 (2003) 1108-1114
20. Izawa I., Nishizawa M., Tomono Y., Ohtakara K., Takahashi T., and Inagaki M. ERBIN associates with p0071, an armadillo protein, at cell-cell junctions of epithelial cells. Genes Cells 7 (2002) 475-485
21. Jaffer Z.M., and Chernoff J. p21-activated kinases: three more join the Pak. Int. J. Biochem. Cell Biol. 34 (2002) 713-717
22. Keski-Oja J., Lyons R.M., and Moses H.L. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-β 1. Cancer Res. 47 (1987) 6451-6458
23. Kissil J.L., Johnson K.C., Eckman M.S., and Jacks T. Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization. J. Biol. Chem. 277 (2002) 10394-10399
24. Kissil J.L., Wilker E.W., Johnson K.C., Eckman M.S., Yaffe M.B., and Jacks T. Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. Mol. Cell 12 (2003) 841-849
25. Massagué J., Seoane J., and Wotton D. Smad transcription factors. Genes Dev. 19 (2005) 2783-2810
26. McDonald C., Chen F.F., Ollendorff V., Ogura Y., Marchetto S., Lécine P., Borg J.-P., and Nunez G. A role for Erbin in the regulation of Nod2-dependent NF-kB signaling. J. Biol. Chem. 280 (2005) 40301-40309
27. Moses H.L., Yang E.Y., and Pietenpol J.A. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63 (1990) 245-247
28. Moustakas A., and Heldin C.H. Non-Smad TGF-β signals. J. Cell Sci. 118 (2005) 3573-3584
29. Nheu T., He H., Hirokawa Y., Walker F., Wood J., and Maruta H. PAK is essential for RAS-induced upregulation of cyclin D1 during the G1 to S transition. Cell Cycle 3 (2004) 71-74
30. Okada T., Lopez-Lago M., and Giancotti F.G. Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane. J. Cell Biol. 171 (2005) 361-371
31. Okada T., You L., and Giancotti F.G. Shedding light on Merlin's wizardry. Trends Cell Biol. 17 (2007) 222-230
32. Rahimi R.A., and Leof E.B. TGF-β signaling: a tale of two responses. J. Cell. Biochem. 102 (2007) 593-608
33. Rangwala R., Banine F., Borg J.P., and Sherman L.S. Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells. J. Biol. Chem. 280 (2005) 11790-11797
34. Roberts A.B., and Sporn M.B. Transforming growth factors. Cancer Surv. 4 (1985) 683-705
35. Roig J., and Traugh J.A. Cytostatic p21 G protein-activated protein kinase g-PAK. Vitam. Horm. 62 (2001) 167-198
36. Surace E.I., Haipek C.A., and Gutmann D.H. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function. Oncogene 23 (2004) 580-587
37. Tang T.K., Chang W.C., Chan W.H., Yang S.D., Ni M.H., and Yu J.S. Proteolytic cleavage and activation of PAK2 during UV irradiation-induced apoptosis in A431 cells. J. Cell. Biochem. 70 (1998) 442-454
38. Tang B., Vu M., Booker T., Santner S.J., Miller F.R., Anver M.R., and Wakefield L.M. TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Invest. 112 (2003) 1116-1124
39. Wakefield L.M., and Sporn M.B. Suppression of carcinogenesis: a role for TGF-β and related molecules in prevention of cancer. Immunol. Ser. 51 (1990) 217-243
40. Wang S., Wilkes M.C., Leof E.B., and Hirschberg R. Imatinib mesylate blocks a non-Smad TGFβ pathway and reduces fibrogenesis in experimental obstructive nephropathy. FASEB J. 19 (2005) 1-11
41. Wilkes M.C., and Leof E.B. TGF-β activation of c-Abl is independent of receptor internalization and regulated by PI3K and PAK2 in mesenchymal cultures. J. Biol. Chem. 281 (2006) 27846-27854
42. Wilkes M.C., Murphy S.J., Garamszegi N., and Leof E.B. Cell-type-specific activation of PAK2 by transforming growth factor β independent of Smad2 and Smad3. Mol. Cell. Biol. 23 (2003) 8878-8889
43. Wilkes M.C., Mitchell H., Gulati-Penheiter S., Doré J.J., Suzuki K., Edens M., Sharma D.K., Pagano R.E., and Leof E.B. Transforming growth factor-b activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res. 65 (2005) 10431-10440
44. Xiao G.-H., Beeser A., Chernoff J., and Testa J.R. p21-activated kinase links Rac-Cdc42 signaling to merlin. J. Biol. Chem. 277 (2002) 883-886
45. Xiao G.H., Gallagher R., Shetler J., Skele K., Altomare D.A., Pestell R.G., Jhanwar S., and Testa J.R. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. Mol. Cell. Biol. 25 (2005) 2384-2394
46. Zhao Z.-S., and Manser E. PAK and other Rho-associated kinases - effectors with surprisingly diverse mechanisms of regulation. Biochem. J. 386 (2005) 201-214